Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 26, 2024; 12(21): 4601-4608
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Premedication | Post medication | Value of difference (post medication- premedication) | P value | |
Maximum diameter of myoma (n = 83, mm) | 23.34 ± 13.63 | 25.73 ± 15.13 | 2.40 | < 0.001 |
Myoma volume (n = 83, mm) | 10.22 ± 16.83 | 13.53 ± 19.78 | 3.31 | < 0.001 |
Uterine volume (n = 83, mm3) | 147.06 ± 102.17 | 144.14 ± 108.64 | -2.92 | 0.67 |
Maximum diameter of adenomyoma (n = 34, mm) | 46.97 ± 14.99 | 44.68 ± 16.48 | -2.3 | 0.19 |
Adenomyoma volume (n = 34, mm3) | 47.82 ± 40.38 | 44.61 ± 51.88 | -3.21 | 0.59 |
Maximum diameter of the cyst (n = 44, mm) | 35.48 ± 11.74 | 27.23 ± 12.31 | -8.25 | < 0.001 |
Volume of cysts (n = 44, mm3) | 19.02 ± 19.48 | 9.99 ± 12.79 | -9.02 | < 0.001 |
Endometrial thickness (n = 83, mm) | 5.89 ± 3.2 | 4.24 ± 1.94 | -1.65 | < 0.001 |
CA125 (n = 13, U/mL) | 45.9 ± 19.5 | 28.2 ± 16.8 | -17.7 | 0.006 |
- Citation: Zhang DY, Huang Y, Peng C, Zhou YF. Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids. World J Clin Cases 2024; 12(21): 4601-4608
- URL: https://www.wjgnet.com/2307-8960/full/v12/i21/4601.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i21.4601